Cargando…

Association between Interferon-Lambda-3 rs12979860, TLL1 rs17047200 and DDR1 rs4618569 Variant Polymorphisms with the Course and Outcome of SARS-CoV-2 Patients

Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection provides a critical host-immunological challenge. Aim: We explore the effect of host-genetic variation in interferon-lambda-3 rs12979860, Tolloid Like–1 (TLL1) rs17047200 and Discoidin domain receptor 1(DDR1) rs461856...

Descripción completa

Detalles Bibliográficos
Autores principales: Agwa, Sara H. A., Kamel, Marwa Mostafa, Elghazaly, Hesham, Abd Elsamee, Aya M., Hafez, Hala, Girgis, Samia Abdo, Ezz Elarab, Hoda, Ebeid, Fatma S. E., Sayed, Safa Matbouly, Sherif, Lina, Matboli, Marwa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230293/
https://www.ncbi.nlm.nih.gov/pubmed/34071309
http://dx.doi.org/10.3390/genes12060830
_version_ 1783713174251372544
author Agwa, Sara H. A.
Kamel, Marwa Mostafa
Elghazaly, Hesham
Abd Elsamee, Aya M.
Hafez, Hala
Girgis, Samia Abdo
Ezz Elarab, Hoda
Ebeid, Fatma S. E.
Sayed, Safa Matbouly
Sherif, Lina
Matboli, Marwa
author_facet Agwa, Sara H. A.
Kamel, Marwa Mostafa
Elghazaly, Hesham
Abd Elsamee, Aya M.
Hafez, Hala
Girgis, Samia Abdo
Ezz Elarab, Hoda
Ebeid, Fatma S. E.
Sayed, Safa Matbouly
Sherif, Lina
Matboli, Marwa
author_sort Agwa, Sara H. A.
collection PubMed
description Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection provides a critical host-immunological challenge. Aim: We explore the effect of host-genetic variation in interferon-lambda-3 rs12979860, Tolloid Like–1 (TLL1) rs17047200 and Discoidin domain receptor 1(DDR1) rs4618569 on host response to respiratory viral infections and disease severity that may probe the mechanistic approach of allelic variation in virus-induced inflammatory responses. Methods: 141 COVID-19 positive patients and 100 healthy controls were tested for interferon-lambda-3 rs12979860, TLL1 rs17047200 and DDR1 rs4618569 polymorphism by TaqMan probe-based genotyping. Different genotypes were assessed regarding the COVID-19 severity and prognosis. Results: There were statistically significant differences between the studied cases and control group with regard to the presence of comorbidities, total leucocytic count, lymphocytic count, CRP, serum LDH, ferritin and D-dimer (p < 0.01). The CC genotype of rs12979860 cytokine, the AA genotype of TLL1 rs17047200 and the AA genotype of the rs4618569 variant of DDR1 showed a higher incidence of COVID-19 compared to the others. There were significant differences between the rs4618569 variant of DDR and the outcome of the disease, with the highest mortality in AG genotype 29 (60.4%) in comparison to 16 (33.3%) and 3 (6.2%) in the AA and GG genotypes, respectively (p = 0.007*), suggesting that the A allele is associated with a poor outcome in the disease. Conclusion: Among people who carry C and A alleles of SNPs IFN-λ rs12979860 and TLL1 rs17047200, respectively, the AG genotype of the DDR1 rs4618569 variant is correlated with a COVID-19 poor outcome. In those patients, the use of anti-IFN-λ 3, TLL1 and DDR1 therapy may be promising for personalized translational clinical practice.
format Online
Article
Text
id pubmed-8230293
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-82302932021-06-26 Association between Interferon-Lambda-3 rs12979860, TLL1 rs17047200 and DDR1 rs4618569 Variant Polymorphisms with the Course and Outcome of SARS-CoV-2 Patients Agwa, Sara H. A. Kamel, Marwa Mostafa Elghazaly, Hesham Abd Elsamee, Aya M. Hafez, Hala Girgis, Samia Abdo Ezz Elarab, Hoda Ebeid, Fatma S. E. Sayed, Safa Matbouly Sherif, Lina Matboli, Marwa Genes (Basel) Article Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection provides a critical host-immunological challenge. Aim: We explore the effect of host-genetic variation in interferon-lambda-3 rs12979860, Tolloid Like–1 (TLL1) rs17047200 and Discoidin domain receptor 1(DDR1) rs4618569 on host response to respiratory viral infections and disease severity that may probe the mechanistic approach of allelic variation in virus-induced inflammatory responses. Methods: 141 COVID-19 positive patients and 100 healthy controls were tested for interferon-lambda-3 rs12979860, TLL1 rs17047200 and DDR1 rs4618569 polymorphism by TaqMan probe-based genotyping. Different genotypes were assessed regarding the COVID-19 severity and prognosis. Results: There were statistically significant differences between the studied cases and control group with regard to the presence of comorbidities, total leucocytic count, lymphocytic count, CRP, serum LDH, ferritin and D-dimer (p < 0.01). The CC genotype of rs12979860 cytokine, the AA genotype of TLL1 rs17047200 and the AA genotype of the rs4618569 variant of DDR1 showed a higher incidence of COVID-19 compared to the others. There were significant differences between the rs4618569 variant of DDR and the outcome of the disease, with the highest mortality in AG genotype 29 (60.4%) in comparison to 16 (33.3%) and 3 (6.2%) in the AA and GG genotypes, respectively (p = 0.007*), suggesting that the A allele is associated with a poor outcome in the disease. Conclusion: Among people who carry C and A alleles of SNPs IFN-λ rs12979860 and TLL1 rs17047200, respectively, the AG genotype of the DDR1 rs4618569 variant is correlated with a COVID-19 poor outcome. In those patients, the use of anti-IFN-λ 3, TLL1 and DDR1 therapy may be promising for personalized translational clinical practice. MDPI 2021-05-28 /pmc/articles/PMC8230293/ /pubmed/34071309 http://dx.doi.org/10.3390/genes12060830 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Agwa, Sara H. A.
Kamel, Marwa Mostafa
Elghazaly, Hesham
Abd Elsamee, Aya M.
Hafez, Hala
Girgis, Samia Abdo
Ezz Elarab, Hoda
Ebeid, Fatma S. E.
Sayed, Safa Matbouly
Sherif, Lina
Matboli, Marwa
Association between Interferon-Lambda-3 rs12979860, TLL1 rs17047200 and DDR1 rs4618569 Variant Polymorphisms with the Course and Outcome of SARS-CoV-2 Patients
title Association between Interferon-Lambda-3 rs12979860, TLL1 rs17047200 and DDR1 rs4618569 Variant Polymorphisms with the Course and Outcome of SARS-CoV-2 Patients
title_full Association between Interferon-Lambda-3 rs12979860, TLL1 rs17047200 and DDR1 rs4618569 Variant Polymorphisms with the Course and Outcome of SARS-CoV-2 Patients
title_fullStr Association between Interferon-Lambda-3 rs12979860, TLL1 rs17047200 and DDR1 rs4618569 Variant Polymorphisms with the Course and Outcome of SARS-CoV-2 Patients
title_full_unstemmed Association between Interferon-Lambda-3 rs12979860, TLL1 rs17047200 and DDR1 rs4618569 Variant Polymorphisms with the Course and Outcome of SARS-CoV-2 Patients
title_short Association between Interferon-Lambda-3 rs12979860, TLL1 rs17047200 and DDR1 rs4618569 Variant Polymorphisms with the Course and Outcome of SARS-CoV-2 Patients
title_sort association between interferon-lambda-3 rs12979860, tll1 rs17047200 and ddr1 rs4618569 variant polymorphisms with the course and outcome of sars-cov-2 patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230293/
https://www.ncbi.nlm.nih.gov/pubmed/34071309
http://dx.doi.org/10.3390/genes12060830
work_keys_str_mv AT agwasaraha associationbetweeninterferonlambda3rs12979860tll1rs17047200andddr1rs4618569variantpolymorphismswiththecourseandoutcomeofsarscov2patients
AT kamelmarwamostafa associationbetweeninterferonlambda3rs12979860tll1rs17047200andddr1rs4618569variantpolymorphismswiththecourseandoutcomeofsarscov2patients
AT elghazalyhesham associationbetweeninterferonlambda3rs12979860tll1rs17047200andddr1rs4618569variantpolymorphismswiththecourseandoutcomeofsarscov2patients
AT abdelsameeayam associationbetweeninterferonlambda3rs12979860tll1rs17047200andddr1rs4618569variantpolymorphismswiththecourseandoutcomeofsarscov2patients
AT hafezhala associationbetweeninterferonlambda3rs12979860tll1rs17047200andddr1rs4618569variantpolymorphismswiththecourseandoutcomeofsarscov2patients
AT girgissamiaabdo associationbetweeninterferonlambda3rs12979860tll1rs17047200andddr1rs4618569variantpolymorphismswiththecourseandoutcomeofsarscov2patients
AT ezzelarabhoda associationbetweeninterferonlambda3rs12979860tll1rs17047200andddr1rs4618569variantpolymorphismswiththecourseandoutcomeofsarscov2patients
AT ebeidfatmase associationbetweeninterferonlambda3rs12979860tll1rs17047200andddr1rs4618569variantpolymorphismswiththecourseandoutcomeofsarscov2patients
AT sayedsafamatbouly associationbetweeninterferonlambda3rs12979860tll1rs17047200andddr1rs4618569variantpolymorphismswiththecourseandoutcomeofsarscov2patients
AT sheriflina associationbetweeninterferonlambda3rs12979860tll1rs17047200andddr1rs4618569variantpolymorphismswiththecourseandoutcomeofsarscov2patients
AT matbolimarwa associationbetweeninterferonlambda3rs12979860tll1rs17047200andddr1rs4618569variantpolymorphismswiththecourseandoutcomeofsarscov2patients